<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Echoiq Limited — News on 6ix</title>
<link>https://6ix.com/company/echoiq-limited</link>
<description>Latest news and press releases for Echoiq Limited on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 28 Apr 2026 02:57:04 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/echoiq-limited" rel="self" type="application/rss+xml" />
<item>
<title>EchoSolv AS deployed into Mount Sinai Health System</title>
<link>https://6ix.com/company/echoiq-limited/news/echosolv-as-deployed-into-mount-sinai-health-system</link>
<guid isPermaLink="true">https://6ix.com/company/echoiq-limited/news/echosolv-as-deployed-into-mount-sinai-health-system</guid>
<pubDate>Tue, 28 Apr 2026 02:57:04 GMT</pubDate>
<description>EchoSolv AS deployed into Mount Sinai Health System</description>
</item>
<item>
<title>Agreement with Mayo Clinic for EchoSolv HF</title>
<link>https://6ix.com/company/echoiq-limited/news/agreement-with-mayo-clinic-for-echosolv-hf</link>
<guid isPermaLink="true">https://6ix.com/company/echoiq-limited/news/agreement-with-mayo-clinic-for-echosolv-hf</guid>
<pubDate>Tue, 24 Mar 2026 02:38:04 GMT</pubDate>
<description>Agreement with Mayo Clinic for EchoSolv HF</description>
</item>
<item>
<title>Update - S&P DJI March 2026 Rebalance of the All Ordinaries</title>
<link>https://6ix.com/company/echoiq-limited/news/update-sandp-dji-march-2026-rebalance-of-the-all-ordinaries-59</link>
<guid isPermaLink="true">https://6ix.com/company/echoiq-limited/news/update-sandp-dji-march-2026-rebalance-of-the-all-ordinaries-59</guid>
<pubDate>Tue, 10 Mar 2026 10:49:03 GMT</pubDate>
<description>Update - S&P DJI March 2026 Rebalance of the All Ordinaries</description>
</item>
<item>
<title>S&P DJI Announces March 2026 Quarterly Rebalance</title>
<link>https://6ix.com/company/echoiq-limited/news/sandp-dji-announces-march-2026-quarterly-rebalance-94</link>
<guid isPermaLink="true">https://6ix.com/company/echoiq-limited/news/sandp-dji-announces-march-2026-quarterly-rebalance-94</guid>
<pubDate>Fri, 06 Mar 2026 11:26:03 GMT</pubDate>
<description>S&P DJI Announces March 2026 Quarterly Rebalance</description>
</item>
<item>
<title>Appendix 4D 31 December 2025</title>
<link>https://6ix.com/company/echoiq-limited/news/appendix-4d-31-december-2025-2</link>
<guid isPermaLink="true">https://6ix.com/company/echoiq-limited/news/appendix-4d-31-december-2025-2</guid>
<pubDate>Thu, 26 Feb 2026 10:43:11 GMT</pubDate>
<description>Appendix 4D 31 December 2025</description>
</item>
<item>
<title>Quarterly Activities Report and Appendix 4C Cash Flow Report</title>
<link>https://6ix.com/company/echoiq-limited/news/quarterly-activities-report-and-appendix-4c-cash-flow-report</link>
<guid isPermaLink="true">https://6ix.com/company/echoiq-limited/news/quarterly-activities-report-and-appendix-4c-cash-flow-report</guid>
<pubDate>Fri, 23 Jan 2026 06:20:08 GMT</pubDate>
<description>Quarterly Activities Report and Appendix 4C Cash Flow Report</description>
</item>
<item>
<title>Response to ASX Price Query</title>
<link>https://6ix.com/company/echoiq-limited/news/response-to-asx-price-query-136</link>
<guid isPermaLink="true">https://6ix.com/company/echoiq-limited/news/response-to-asx-price-query-136</guid>
<pubDate>Fri, 23 Jan 2026 03:39:16 GMT</pubDate>
<description>Response to ASX Price Query</description>
</item>
<item>
<title>Formal lodgement of FDA submission for EchoSolv HF</title>
<link>https://6ix.com/company/echoiq-limited/news/formal-lodgement-of-fda-submission-for-echosolv-hf</link>
<guid isPermaLink="true">https://6ix.com/company/echoiq-limited/news/formal-lodgement-of-fda-submission-for-echosolv-hf</guid>
<pubDate>Mon, 15 Dec 2025 02:40:12 GMT</pubDate>
<description>Formal lodgement of FDA submission for EchoSolv HF</description>
</item>
<item>
<title>Echo IQ to Present at the Life Sciences Virtual Investor Forum on 11th December</title>
<link>https://6ix.com/company/echoiq-limited/news/echo-iq-present-life-sciences-171300280</link>
<guid isPermaLink="true">https://6ix.com/company/echoiq-limited/news/echo-iq-present-life-sciences-171300280</guid>
<pubDate>Mon, 08 Dec 2025 17:13:00 GMT</pubDate>
<description>Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.comSYDNEY, Dec. 08, 2025 (GLOBE NEWSWIRE) -- AI and Medical Technology company Echo IQ (“the Company” or “Echo IQ”) (ASX: EIQ) today announced that Dustin Haines, Chief Executive Officer, will present live at Life Sciences Virtual Investor Forum hosted by VirtualInvestorConferences.com, on 11th December. Presentation DetailsEvent: Life Sciences Virtual Investor</description>
</item>
<item>
<title>Validation study for EchoSolv HF completed at the Mayo Clinic – Study delivers exceptional results</title>
<link>https://6ix.com/company/echoiq-limited/news/validation-study-echosolv-hf-completed-142000887</link>
<guid isPermaLink="true">https://6ix.com/company/echoiq-limited/news/validation-study-echosolv-hf-completed-142000887</guid>
<pubDate>Mon, 24 Nov 2025 14:20:00 GMT</pubDate>
<description>Clinical validation successfully completed with Mayo Clinic Platform’s Validate program – marking the final clinical requirement prior to FDA 510(k) submission EchoSolv HF validation met the primary endpoint, delivering performance exceeding company expectations in detecting heart failure on an independent dataset Study was undertaken across 17,000 individual patient echocardiograms from the Mayo Clinic Platform with results highlighting: Sensitivity of 99.5%, accurately identifying true positiv</description>
</item>
<item>
<title>Exceptional Results from Validation Study for EchoSolv HF</title>
<link>https://6ix.com/company/echoiq-limited/news/exceptional-results-from-validation-study-for-echosolv-hf</link>
<guid isPermaLink="true">https://6ix.com/company/echoiq-limited/news/exceptional-results-from-validation-study-for-echosolv-hf</guid>
<pubDate>Mon, 24 Nov 2025 02:46:07 GMT</pubDate>
<description>Exceptional Results from Validation Study for EchoSolv HF</description>
</item>
<item>
<title>Echo IQ to Participate in the Piper Sandler 37th Annual Healthcare Conference</title>
<link>https://6ix.com/company/echoiq-limited/news/echo-iq-participate-piper-sandler-210500824</link>
<guid isPermaLink="true">https://6ix.com/company/echoiq-limited/news/echo-iq-participate-piper-sandler-210500824</guid>
<pubDate>Fri, 21 Nov 2025 21:05:00 GMT</pubDate>
<description>SYDNEY, Nov. 21, 2025 (GLOBE NEWSWIRE) -- AI and Medical Technology company Echo IQ (“the Company” or “Echo IQ”) (ASX: EIQ), today announced that Dustin Haines, Chief Executive Officer, will participate in a fireside chat at the upcoming Piper Sandler 37th Annual Healthcare Conference at the Lotte New York Palace. The fireside chat will take place on Tuesday, December 2, 2025, at 12:50 p.m. Eastern Time. Event: Piper Sandler 37th Annual Healthcare ConferenceDate: Tuesday, December 2, 2025Time: 1</description>
</item>
<item>
<title>Echo IQ Highlights Market Potential for EchoSolv AS Following Presentation of New Data for Severe Aortic Stenosis (AS) Presented at AHA Scientific Sessions 2025</title>
<link>https://6ix.com/company/echoiq-limited/news/echo-iq-highlights-market-potential-210500035</link>
<guid isPermaLink="true">https://6ix.com/company/echoiq-limited/news/echo-iq-highlights-market-potential-210500035</guid>
<pubDate>Wed, 12 Nov 2025 21:05:00 GMT</pubDate>
<description>Investigator-initiated study shows potential for EchoSolv AS to drive improved patient outcomes when used to support cardiologist in identifying severe AS particularly in womenNEDA study of 1.2M patients’ echocardiograms reveals gap in standard-of-care for severe AS; highlighting significant medical need for improved monitoring and diagnosis SYDNEY, Nov. 12, 2025 (GLOBE NEWSWIRE) -- AI and Medical Technology company Echo IQ (“the Company” or “Echo IQ”) (ASX: EIQ) today announced that overwhelmin</description>
</item>
<item>
<title>Quarterly Activities and Appendix 4C Cash Flow Report</title>
<link>https://6ix.com/company/echoiq-limited/news/quarterly-activities-and-appendix-4c-cash-flow-report-1</link>
<guid isPermaLink="true">https://6ix.com/company/echoiq-limited/news/quarterly-activities-and-appendix-4c-cash-flow-report-1</guid>
<pubDate>Thu, 30 Oct 2025 09:41:05 GMT</pubDate>
<description>Quarterly Activities and Appendix 4C Cash Flow Report</description>
</item>
<item>
<title>Category III CPT code application update</title>
<link>https://6ix.com/company/echoiq-limited/news/category-iii-cpt-code-application-update</link>
<guid isPermaLink="true">https://6ix.com/company/echoiq-limited/news/category-iii-cpt-code-application-update</guid>
<pubDate>Mon, 06 Oct 2025 07:59:11 GMT</pubDate>
<description>Category III CPT code application update</description>
</item>
<item>
<title>Trading Halt</title>
<link>https://6ix.com/company/echoiq-limited/news/trading-halt-491</link>
<guid isPermaLink="true">https://6ix.com/company/echoiq-limited/news/trading-halt-491</guid>
<pubDate>Mon, 06 Oct 2025 03:29:11 GMT</pubDate>
<description>Trading Halt</description>
</item>
<item>
<title>Pause in Trading</title>
<link>https://6ix.com/company/echoiq-limited/news/pause-in-trading-295</link>
<guid isPermaLink="true">https://6ix.com/company/echoiq-limited/news/pause-in-trading-295</guid>
<pubDate>Mon, 06 Oct 2025 03:09:19 GMT</pubDate>
<description>Pause in Trading</description>
</item>
<item>
<title>Strong Operational Momentum</title>
<link>https://6ix.com/company/echoiq-limited/news/strong-operational-momentum</link>
<guid isPermaLink="true">https://6ix.com/company/echoiq-limited/news/strong-operational-momentum</guid>
<pubDate>Thu, 02 Oct 2025 04:17:06 GMT</pubDate>
<description>Strong Operational Momentum</description>
</item>
<item>
<title>Update on Category III CPT Code Application</title>
<link>https://6ix.com/company/echoiq-limited/news/update-on-category-iii-cpt-code-application</link>
<guid isPermaLink="true">https://6ix.com/company/echoiq-limited/news/update-on-category-iii-cpt-code-application</guid>
<pubDate>Fri, 19 Sep 2025 06:47:03 GMT</pubDate>
<description>Update on Category III CPT Code Application</description>
</item>
<item>
<title>Preliminary Final Report</title>
<link>https://6ix.com/company/echoiq-limited/news/preliminary-final-report-153</link>
<guid isPermaLink="true">https://6ix.com/company/echoiq-limited/news/preliminary-final-report-153</guid>
<pubDate>Fri, 29 Aug 2025 06:21:05 GMT</pubDate>
<description>Preliminary Final Report</description>
</item>
</channel>
</rss>